Old Web
English
Sign In
Acemap
>
authorDetail
>
Domingo G. Perez
Domingo G. Perez
Medicine
Bevacizumab
Carboplatin
Phases of clinical research
Pathology
3
Papers
301
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A randomized phase 2 study of temozolomide and bevacizumab or nab-paclitaxel, carboplatin, and bevacizumab in patients with unresectable stage IV melanoma : a North Central Cancer Treatment Group study, N0775.
2013
Cancer
Lisa A. Kottschade
Vera Jean Suman
Domingo G. Perez
Robert R. McWilliams
Judith S. Kaur
T. Amatruda
Francois J. Geoffroy
Howard M. Gross
Peter A. Cohen
Anthony J. Jaslowski
Matthew L. Kosel
Svetomir Nenad Markovic
Show All
Source
Cite
Save
Citations (62)
Epratuzumab with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated diffuse large B-cell lymphoma
2011
Blood
Ivana Micallef
Matthew J. Maurer
Gregory A. Wiseman
Daniel Nikcevich
Paul J. Kurtin
Michael W. Cannon
Domingo G. Perez
Gamini S. Soori
Brian K. Link
Thomas Matthew Habermann
Thomas Elmer Witzig
Show All
Source
Cite
Save
Citations (116)
Phase 2 trial of carboplatin, weekly paclitaxel, and biweekly bevacizumab in patients with unresectable stage IV melanoma: A North Central Cancer Treatment Group study, N047A
2009
Cancer
Domingo G. Perez
Vera Jean Suman
Tom R. Fitch
T. Amatruda
Roscoe F. Morton
Shamim Z. Jilani
Costas L. Constantinou
James R. Egner
Lisa A. Kottschade
Svetomir Nenad Markovic
Show All
Source
Cite
Save
Citations (123)
1